Free to-play fantasy sports stock exchange Fandex has taken a step forward towards securing its intellectual property, announcing today that it has received a US patent for its platform.Fandex

The United States Patent and Trademark Office (USPTO) granted US patent No 11,436,674 to the fantasy business which covers certain aspects of the company’s fantasy sports team and player stock exchange.

“This is a huge moment for us here at Fandex as our team has worked hard since 2017 to create this patented platform and we look forward to speaking with the market leaders in igaming to discuss licensing and other partnerships” said Matt D’Alessandro, CEO of Fandex. “The patent not only adds to our intellectual property portfolio covering our novel fantasy sports exchange, but it also strengthens our competitive advantage.”

D’Alessandro outlined the business’ future IP strategy.

“We have additional patents pending as part of our IP protection strategy, and we will continue our innovation efforts to further enhance our market position and drive revenue growth.”

[Read full story on iGB North America]

Want To Keep Up To date with our latest news and information? Please enter your email address below to be added to our mailing list

Bookielink.com is operated by Blueinic B.V., a company incorporated under the laws of Curaçao with Company Number 140279 and has a valid Certificate of Operation. Blueinic B.V. has an application (OGL/2024/314/1090) for a gaming license in progress with the Curaçao Gaming Control Board. Until that process is concluded, based on a transitional arrangement, the company is permitted to continue its operations under this Certificate of Operation. This Certificate of Operation is subject to the National Ordinance on Offshore Games of Hazard (Landsverordening buitengaatse hazardspelen, P.B. 1993, no. 63) (NOOGH)

Bookielink.com © 2024 All rights reserved.

Age Verification

You must be at least 18 years old or older to visit this website.

By entering this site you are agreeing to the Terms & Conditions and Privacy Policy.